跳至主要内容
临床试验/NCT02464943
NCT02464943Approved For Marketing不适用

Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissections

Cook Research Incorporated3 个研究点 分布在 1 个国家开始时间: 2015年6月8日最近更新:
适应症

试验速览

阶段
不适用
状态
Approved For Marketing
试验地点
3

研究概览

简要总结

The Zenith® Dissection extended study is to collect confirmatory safety and effectiveness data on the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.

研究设计

研究类型
Expanded Access

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • < 18 years of age
  • Other medical condition(e.g., cancer, congestive heart failure) that may cause the patient to be non-compliant with the protocol, confound the results, or is associated with limited life expectancy (i.e., < 2 years)
  • Pregnant, breast-feeding, or planning on becoming pregnant within 60 months
  • Unwilling to unable to comply with the follow-up schedule
  • Inability or refusal to give informed consent
  • Simultaneously participating in another investigative device or drug study. (The patient must have completed the primary endpoint of any previous study at least 30 days prior to enrollment in this study)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验